Lingru Xue

Lingru Xue

Auto-generated profile, based on publicly available information

Lingru Xue

School of Medicine and Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA 94158, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
HNHao G Nguyen
Hao G Nguyen
CCCrystal S. Conn
Crystal S. Conn
YKYae Kye
Yae Kye
LXLingru Xue
Lingru Xue
CFCraig M. Forester
Craig M. Forester
DRDavide Ruggero
Davide Ruggero
The PERK-eIF2α pathway is activated in aggressive prostate cancer and associated with patient outcome, providing a therapeutic target for the disease.